Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. - Concepedia

Concepedia

Publication | Closed Access

Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.

92

Citations

0

References

1997

Year

Adnan Kastrati, Helmut Schühlen, Jöerg Hausleiter, Hanna Walter, Eva Zitzmann-Roth, Martin Hadamitzky, Shpend Elezi, Kurt Ulm, Josef Dirschinger, Franz-Josef Neumann,

Abstract

This study shows that combined antiplatelet therapy (aspirin plus ticlopidine) administered for 4 weeks after coronary Palmaz-Schatz stent placement does not result in a detectable benefit for the prevention of restenosis compared with conventional anticoagulant therapy (phenprocoumon with initial overlapping heparin plus aspirin).